IONS Ionis Pharmaceuticals
- 34.810
- +0.120+0.35%
- 36.290
- +1.480+4.25%
Ionis Pharmaceuticals News
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hayden Michael R
Ionis Pharmaceuticals | 8-K: Current report
Ionis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BB Biotech AG(5.0%),Biotech Invest N.V.(5.0%)
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Swayze Eric
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Monia Brett P
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director LOSCALZO JOSEPH
Ionis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. Rowe Price Investment Management, Inc.(9.0%)
Ionis Pharmaceuticals | 144/A: Others
Ionis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ionis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ionis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ionis Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Wellington Management Group LLP(5.76%),Wellington Group Holdings LLP(5.76%), etc.
Ionis Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Ionis Pharmaceuticals | 8-K: Ionis reports third quarter 2024 financial results
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Swayze Eric
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Devers Shannon L.
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Devers Shannon L.
Ionis Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Devers Shannon L.
Ionis Pharmaceuticals | 8-K: Current report
Ionis Pharmaceuticals | 424B5: Prospectus
No Data